[PUBLIC REPORT] World Diabetes Day: iCan i6, the First CGM Sensor in Mauritius that Transforms Daily Life

[PUBLIC REPORT] On World Diabetes Day, celebrated annually on November 14, it is essential to highlight the technological advancements that make life easier for people living with this chronic disease. Among these advancements is the continuous glucose monitor iCan, launched in May 2024, which stands out as a pioneering innovation in Mauritius.

The iCan was the very first CGM (Continuous Glucose Monitoring) sensor successfully marketed in Mauritius. Since its introduction, it has already been used over 2000 times, marking a true revolution in glucose tracking.

Today, Health Focus Ltd introduces the iCan i6, an improved version that combines ease of use, increased accuracy, and optimal comfort. This discreet device can be applied in seconds, painlessly, and transmits glucose data in real-time via an intuitive mobile app. It allows users to monitor their glucose levels 24/7, without repeated pricks or constraints.

The iCan i6 operates continuously for 15 days, providing a comprehensive view of glucose fluctuations day and night. Available at pharmacies for Rs 3275, or just Rs 218.33 per day, it makes cutting-edge technology accessible to a wide audience. This price includes the sensor, access to the mobile app, and dedicated technical support.

On this World Diabetes Day, the iCan i6 represents a concrete response to the challenges of glucose monitoring. It not only enables better disease management but also significantly enhances quality of life. Healthcare professionals can also monitor their patients' data remotely and proactively adjust treatments.

Marketed by Health Focus Ltd, the iCan i6 marks a new milestone in the democratization of connected medical devices in Mauritius. This sensor is not just a medical tool, but a true ally in daily life, giving patients control over their health.

On this day dedicated to awareness and prevention, the iCan i6 reminds us that innovation can serve humanity — for a calmer, freer, and better-managed future in the face of diabetes.